Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (9.836)

71

A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children

enthalten in: Drug design, development and therapy | 2024

von Wang, M. | Gao, X. | Zhang, L.

72

Bimekizumab for the treatment of psoriatic arthritis

enthalten in: Expert review of clinical immunology | 2024

von Tanaka, Y. | Shaw, S.

73

Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease : A Systematic Review and Meta-Analysis

enthalten in: Annals of family medicine | 2024

von Ebell, M. | Barry, H. | Baduni, K. | +1

74

Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis : What Have We Learned?

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2024

von Avci, A. | Feist, E. | Burmester, G.

75

Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors

enthalten in: Respiratory investigation | 2024

von Tamiya, A.

76

NeoSCORE II : three vs four cycles of neoadjuvant sintilimab + chemotherapy for squamous non-small-cell lung cancer

enthalten in: Future oncology (London, England) | 2024

von Zhang, X. | Shao, M. | Yao, J. | +10

77

Spesolimab for the Treatment of Generalized Pustular Psoriasis

enthalten in: Drugs | 2024

von Bernardo, D. | Thaçi, D. | Torres, T.

78

Tremelimumab : A Review in Advanced or Unresectable Hepatocellular Carcinoma

enthalten in: Targeted oncology | 2024

von France, N. | Blair, H.

ErratumIn: Target Oncol. 2024 Mar 20;:. - PMID 38507179

79

A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis

enthalten in: Dermatitis : contact, atopic, occupational, drug | 2024

von Tsai, J. | Tsai, T.

80

Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer : A case report and literature review

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Kapagan, T. | Aksu, F. | Yuzkan, S. | +2